Hiroko Masuda
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 22
- Cancer Cells and Metastasis 5
- Cancer Treatment and Pharmacology 5
- Cancer Immunotherapy and Biomarkers 4
- Cancer Diagnosis and Treatment 3
- HER2/EGFR in Cancer Research 3
-
- Breast Cancer Treatment Studies 15
- Cancer, Lipids, and Metabolism 5
- Co-authors
- Naoto T. Ueno (28 shared papers)Gabriel N. Hortobágyi (14 shared papers)Hiroyoshi Doihara (4 shared papers)Chandra Bartholomeusz (3 shared papers)Dongwei Zhang (2 shared papers)Vicente Valero (10 shared papers)W. Fraser Symmans (4 shared papers)Ana M. González-Angulo (3 shared papers)
- Journals
- Cancer Research (4 papers)Breast Cancer Research and Treatment (4 papers)Annals of Oncology (4 papers)Breast Cancer (4 papers)The Oncologist (2 papers)
- Partner nations
- JapanUnited StatesBelgium
In The Last Decade
Hiroko Masuda
72 papers receiving 3.0k citations
Hiroko Masuda's Hit Papers
Peers
Comparison fields: 5 of 119
- Cancer Research 922
- Oncology 1.0k
- Molecular Medicine 101
- Molecular Biology 995
- Pulmonary and Respiratory Medicine 375
Countries citing papers authored by Hiroko Masuda
This map shows the geographic impact of Hiroko Masuda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroko Masuda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroko Masuda more than expected).
Fields of papers citing papers by Hiroko Masuda
This network shows the impact of papers produced by Hiroko Masuda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroko Masuda. The network helps show where Hiroko Masuda may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroko Masuda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Role of epidermal growth factor receptor in breast cancer Hit paper breakdown → | 2012 | 631 |
| 2 | Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes Hit paper breakdown → | 2013 | 550 |
| 3 | 1994 | 198 | |
| 4 | 2010 | 161 | |
| 5 | 2013 | 117 | |
| 6 | 2013 | 97 | |
| 7 | 2013 | 79 | |
| 8 | 2013 | 76 | |
| 9 | 2015 | 69 | |
| 10 | 2014 | 69 | |
| 11 | 2010 | 60 | |
| 12 | 2013 | 52 | |
| 13 | 2013 | 43 | |
| 14 | 2003 | 42 | |
| 15 | 1994 | 41 | |
| 16 | 1998 | 40 | |
| 17 | 2014 | 38 | |
| 18 | 1994 | 38 | |
| 19 | 2017 | 35 | |
| 20 | 2017 | 35 |
About Hiroko Masuda
Hiroko Masuda is a scholar working on Oncology, Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine and Surgery, having authored 73 papers that have together received 3.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (15 papers), Advanced Breast Cancer Therapies (6 papers), Cancer Cells and Metastasis (5 papers), Cancer Treatment and Pharmacology (5 papers), Cancer, Lipids, and Metabolism (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Diagnosis and Treatment (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Cancer Research (922 citations), Oncology (1.0k citations), Molecular Medicine (101 citations), Molecular Biology (995 citations) and Pulmonary and Respiratory Medicine (375 citations). Hiroko Masuda has collaborated with scholars based in Japan, United States and Belgium. Frequent co-authors include Naoto T. Ueno, Gabriel N. Hortobágyi, Hiroyoshi Doihara, Chandra Bartholomeusz, Dongwei Zhang, Vicente Valero, W. Fraser Symmans, Ana M. González-Angulo, Kazunori Hirayoshi and K. Nagata. Their work appears in journals such as Cancer Research, Breast Cancer Research and Treatment, Annals of Oncology, Breast Cancer and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.